Human papillomavirus (HPV) is now established as the principal cause of an increase in
incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous …

End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV)
virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct …

Large-scale epidemiologic studies have been invaluable for elaboration of the causal
relationship between persistent detection of genital human papillomavirus (HPV) infection …

Context Human papillomavirus (HPV) infection is the principal cause of a distinct form of
oropharyngeal squamous cell carcinoma that is increasing in incidence among men in the …

Human papillomavirus (HPV) infection of the genital tract is common in young sexually
active individuals, the majority of whom clear the infection without overt clinical disease …

Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …

Individuals with human papillomavirus (HPV)-related disease remain at risk for subsequent
HPV infection and related disease after treatment of specific lesions. Prophylactic HPV …

Background Tobacco use and alcohol consumption are still important risk factors for head
and neck cancer (HNC) in developing countries, even though decreasing in tobacco …